Vioxx (rofecoxib) is a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. It was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children. Merck recently announced a withdrawal of Vioxx after a long-term study was halted because of an increased risk of serious cardiovascular events among study patients taking the drug.
A study in June 2000 conducted by Merck found an increased risk of serious cardiovascular events, such as heart attacks and strokes, in patients taking Vioxx compared to patients taking naproxen, another NSAID. Based on the findings of this and other controlled clinical trials, the FDA implemented labeling changes in 2002 to include information about the increased risk of these cardiovascular events. In September 2004, Merck recalled Vioxx from all markets in the U.S. and worldwide due to concerns about the drug's safety.
Lopez, Hodes, Milman & Skikos is aggressively pursuing litigation on behalf of individuals at risk because of their use of Vioxx. There are strict time limits for starting a lawsuit that vary from state to state. If you or a loved one suffered a stroke or heart attack while taking Vioxx, it is very important that you contact our attorneys as soon as possible to determine if you have a case.
Click for additional information
